A 1-year-old man named William Shakespeare Is the second person to receive the COVID-19 vaccine.


An 81-year-old man became another person Get the COVID-19 vaccine in the UK Tuesday, but he got worldwide attention on his name: William Shakespeare.

Shakespeare, who hails from Wicks, Ravikshire, in the county where the famous English poet was born, took his pill at the University Hospital Spital Cry Ventry. Shortly after receiving the Pfizer / Bioentech vaccine, Shakespeare said that getting one was “groundbreaking” for him.

“It can change our lives from now on, can’t it?” He said. “It’s starting to change our lives and our lifestyles.”

The first 800,000 doses of the Pfizer vaccine in the UK are going for people over the age of 80, who are either hospitalized or have already scheduled outpatient visits with nursing home workers. U.S. The UK will launch the project after drug regulator Pfizer and a German bioentech vaccine were given emergency powers by British regulators on 2 December. The first recipient was grandmother Margaret Keenan, who turns 91 next week.

As far as Shakespeare is concerned, the late Shakespeare, such as “Taming the F-Dhru” and “The Two Gentlemen of Verona” under the name Octogerianer, received a lukewarm response from many, mostly punline puns.

One user referred to “Hamlet” To tweet About England’s most popular patient: “If the patient for the Margaret Keenan vaccine is 1A, will William Shakespeare be 2B, or not 2B …?”

In response to a tweet, a woman who claimed to be Shakespeare’s niece said she would like to see her family soon.

“He’s my lovely uncle you’re talking about,” he said. “And at some point he will want to see his wife, children and grandchildren who can’t visit him at the moment. Very worthy recipient.”

Matt Hancock, the UK’s health secretary, shed tears in a television interview after hearing that Shakespeare had been vaccinated.

“It’s been such a tough year for a lot of people and William Shakespeare has put it so simply that for everyone we can move on with our lives.”

U.S. And the authorities of the European Union, the U.S. Despite rival products developed by biotechnology company Modernna and collaboration between Oxford University and drugmaker AstraZeneca, the vaccine is also being reviewed by Shakespeare.

.